Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,132 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligands.
Yano S, Takeuchi S, Nakagawa T, Yamada T. Yano S, et al. Cancer Sci. 2012 Jul;103(7):1189-94. doi: 10.1111/j.1349-7006.2012.02279.x. Epub 2012 May 9. Cancer Sci. 2012. PMID: 22435662 Free PMC article. Review.
Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB Jr, Ellis LM. Zebrowski BK, et al. Among authors: yano s. Clin Cancer Res. 1999 Nov;5(11):3364-8. Clin Cancer Res. 1999. PMID: 10589746
Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ. Yano S, et al. Clin Cancer Res. 2000 Mar;6(3):957-65. Clin Cancer Res. 2000. PMID: 10741721
Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis.
Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, Ellis LM, Davis DW, McConkey DJ, Fidler IJ. Yano S, et al. Cancer Res. 2000 Sep 1;60(17):4959-67. Cancer Res. 2000. PMID: 10987313
Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.
Goto H, Yano S, Zhang H, Matsumori Y, Ogawa H, Blakey DC, Sone S. Goto H, et al. Among authors: yano s. Cancer Res. 2002 Jul 1;62(13):3711-5. Cancer Res. 2002. PMID: 12097279
Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxin.
Fan D, Yano S, Shinohara H, Solorzano C, Van Arsdall M, Bucana CD, Pathak S, Kruzel E, Herbst RS, Onn A, Roach JS, Onda M, Wang QC, Pastan I, Fidler IJ. Fan D, et al. Among authors: yano s. Mol Cancer Ther. 2002 Jun;1(8):595-600. Mol Cancer Ther. 2002. PMID: 12479219
Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.
Kanematsu T, Yano S, Uehara H, Bando Y, Sone S. Kanematsu T, et al. Among authors: yano s. Oncol Res. 2003;13(5):289-98. doi: 10.3727/096504003108748348. Oncol Res. 2003. PMID: 12688680
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J. Fukuoka M, et al. Among authors: yano s. J Clin Oncol. 2003 Jun 15;21(12):2237-46. doi: 10.1200/JCO.2003.10.038. Epub 2003 May 14. J Clin Oncol. 2003. PMID: 12748244 Clinical Trial.
Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules.
Yano S, Nishioka Y, Goto H, Sone S. Yano S, et al. Cancer Sci. 2003 Jun;94(6):479-85. doi: 10.1111/j.1349-7006.2003.tb01469.x. Cancer Sci. 2003. PMID: 12824870 Review.
A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa").
Yano S, Kanematsu T, Miki T, Aono Y, Azuma M, Yamamoto A, Uehara H, Sone S. Yano S, et al. Cancer Sci. 2003 May;94(5):453-8. doi: 10.1111/j.1349-7006.2003.tb01464.x. Cancer Sci. 2003. PMID: 12824893
2,132 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback